FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/RXRX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Recursion Pharmaceuticals Inc (RXRX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Recursion Pharmaceuticals (RXRX) trades at $3.80, up 2.7% with a bullish technical signal. The company shows significant revenue growth but deep losses, with a -962% net margin and negative ROE. Recent partnerships with Tempus and Roche expand its AI drug discovery platform, though earnings missed in Q2 2026 after two beats. Analyst consensus is mixed with 40% buy ratings.
RXRX presents high-risk growth potential through AI-driven drug development, supported by strategic partnerships and pipeline expansion. However, persistent losses, cash burn, and competitive pressures pose substantial risks. The stock's valuation relies heavily on future pipeline success rather than current fundamentals.
Read full analysis

Key Stats

  • Market Cap
    $2.29B
  • Volume
    16,055,282
  • Sector
    Health
  • 52W High
    $5.91
  • 52W Low
    $2.84
  • Typical Hold Time
    22 Days
  • Enterprise Value
    $1.82B
  • Div Yield
    -
  • Trading Activity
    99% Sell | 1% Buy
$4.03
52W Low: $2.84
30 Mar 2026
52W High: $5.91
28 Oct 2025

Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $5.91, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Most Recent News

Content is generated by Aura AI

LUXEED launches global media test drive showcasing luxury MPV LLounge and sports model Stormax.

LUXEED held a global media test drive event in Wuhu with 15 automotive media and influencers from UAE, Thailand, and Indonesia. Participants evaluated the luxury MPV LLounge and sports model Stormax over a 185-km route combining highways and mountain...

Market News
1 hour ago
Not Specified
Bullish
news icon
LUXEED launches global media test drive showcasing luxury MPV LLounge and sports model Stormax.

India's plastics market to reach $68.41B by 2032, driven by packaging and electric vehicle demand.

India's plastics industry is projected to grow from USD 49.98 billion in 2027 to USD 68.41 billion by 2032, at a CAGR of 6.48%. Growth is fueled by rising demand in packaging, pharmaceuticals, electric two-wheelers, and construction, alongside polyme...

Market News
2 hours ago
Mordor Intelligence
Bullish
news icon
India's plastics market to reach $68.41B by 2032, driven by packaging and electric vehicle demand.

Natera, Impinj, and Hamilton Lane beat earnings expectations; Cardinal Infrastructure lags despite strong revenue.

Natera and Impinj reported stronger-than-expected quarterly results, with Impinj achieving record revenue and profitability. Hamilton Lane also exceeded revenue and earnings forecasts, positively impacting its shares. However, Cardinal Infrastructure...

4 hours ago
Seeking Alpha
Neutral
Natera, Impinj, and Hamilton Lane beat earnings expectations; Cardinal Infrastructure lags despite strong revenue.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $2.29B
  • Volume
    16,055,282
  • Sector
    Health
  • 52W High
    $5.91
  • 52W Low
    $2.84
  • Typical Hold Time
    22 Days
  • Enterprise Value
    $1.82B
  • Div Yield
    -
  • Trading Activity
    99% Sell | 1% Buy
$4.03
52W Low: $2.84
30 Mar 2026
52W High: $5.91
28 Oct 2025

Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $5.91, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!